RASSIDATOU RADJI: Open Payments
NPI 1407439409 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 18 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $442 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $246 |
| Janssen Pharmaceuticals, Inc | 5 | $229 |
| Teva Pharmaceuticals USA, Inc. | 4 | $185 |
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Lundbeck LLC | 3 | $68 |
| ABBVIE INC. | 2 | $40 |
Products named: ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, INGREZZA, ABILIFY ASIMTUFII, VRAYLAR, REXULTI.
Industry payments across MD — which companies pay providers there.
